Its announcement will come over the heels of an identical licensing arrangement offered in February to Adastra Labs, which had until now focused on crafting cannabis extracts. Adastra's license also will allow it to provide and sell psilocybin and psilocin – hallucinogens far more typically often called magic mushrooms that generate effects just